63 results
Page 3 of 4
8-K
EX-99.1
69t5v cf6v
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am
S-3
EX-1.2
tl6x52x4e
4 Oct 19
Shelf registration
4:06pm
DEFA14A
kbfcope4no8v88b
26 Apr 19
Additional proxy soliciting materials
12:00am
DEF 14A
slixfsy9 qyc
26 Apr 19
Definitive proxy
12:00am
10-K
EX-3.2
91dvpsgdc ivd6j
1 Apr 19
Annual report
12:00am
10-K
cyembx
1 Apr 19
Annual report
12:00am
10-Q
oa7j1xsvq1zkbv2n4sm7
14 Nov 18
Quarterly report
12:00am
10-Q
EX-3.2
mlb0d
14 Nov 18
Quarterly report
12:00am
DRS/A
er3a1opfkv8 73x
10 Jul 18
Draft registration statement (amended)
12:00am
DRS
EX-4.3
f00xzi7i g0h
1 Jun 18
Draft registration statement
12:00am
DRS
EX-4.5
isvdl yd4tqx9bog
1 Jun 18
Draft registration statement
12:00am
DRS
EX-10.3
q5ey 5ktsxgk1
1 Jun 18
Draft registration statement
12:00am
DRS
bkr3969s9w1fkvsr8guh
1 Jun 18
Draft registration statement
12:00am